Warning: Undefined array key "network" in /hshare1/ZETTAI_path_WA_slash_usr_slash_proj_KARA/usr/proj/tcng/htdocs/tcng.php on line 565
Edge
KPNA1 → CSNK1D
Networks Including this Edge
| GSE10327_egf1520 - GSE10327 - SiGN-BN HC+Bootstrap | mRNA expression data of 62 human medulloblastoma tumors |
| GSE10445_egf1520 - GSE10445 - SiGN-BN HC+Bootstrap | MERLION LUNG CANCER STUDY |
| GSE12276_egf1520 - GSE12276 - SiGN-BN HC+Bootstrap | Expression data from primary breast tumors |
| GSE13898_egf1520 - GSE13898 - SiGN-BN HC+Bootstrap | Robust prognostic biomarkers for EAC identified by systems-level characterization of tumor transcriptome |
| GSE14764_egf1520 - GSE14764 - SiGN-BN HC+Bootstrap | A Prognostic Gene Expression Index in Ovarian Cancer |
| GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| GSE20181_egf1520 - GSE20181 - SiGN-BN HC+Bootstrap | Letrozole (Femara) early and late responses to treatment |
| GSE20916_egf1520 - GSE20916 - SiGN-BN HC+Bootstrap | Modeling oncogenic signaling in colon tumors by multidirectional analyses of microarray data |
| GSE2113_egf1520 - GSE2113 - SiGN-BN HC+Bootstrap | Plasma cell dyscrasias expression profiles associated with distinct IGH translocations in multiple myeloma |
| GSE5462_egf1520 - GSE5462 - SiGN-BN HC+Bootstrap | Letrozole (Femara) early response to treatment |
| GSE8139_egf1520 - GSE8139 - SiGN-BN HC+Bootstrap | Expression data from MCF7/HER2-18 xenografts |
| GSE8141_egf1520 - GSE8141 - SiGN-BN HC+Bootstrap | Expression data from MCF7 wt and MCF7/HER2-18 xenografts |
| GSE9169_egf1520 - GSE9169 - SiGN-BN HC+Bootstrap | Gene expression during neuronal differentiation in two subtypes of SH-SY5Y |
